Research area
Drug Delivery & Nanomedicine
Therapeutic delivery systems, targeting and medical nanoparticles across diseases.
-
Evidence date ·What must happen for magnetic particles to help immune cells respond to tumors?
Review or Meta-AnalysisA June 2026 review links magnetic heating and iron chemistry to immune changes in experiments. Mouse studies offer clues, while delivery and safety remain hurdles.
-
Evidence date ·Could tiny particles protect a joint affected by osteoarthritis?
Review or Meta-AnalysisAn April 2026 review examines particles designed to penetrate cartilage or respond to oxidative stress. Its highlighted results come from animal and tissue studies.
-
Evidence date ·How immune-cell particles might carry cancer-fighting instructions
Review or Meta-AnalysisDendritic-cell vesicles can carry tumor antigens and molecules that shape immune responses. A 2026 review identifies delivery and production barriers to clinical use.
-
Evidence date ·Clearing or quieting senescent cells changes the delivery challenge
Review or Meta-AnalysisThe review surveys carriers designed to deliver drugs to senescent cells. An enzyme proposed to trigger release also appears in other cells.
-
Evidence date ·How hyaluronic acid could carry treatment and change how cells meet
Review or Meta-AnalysisA September 2025 review describes hyaluronic acid carriers and CD44-linked cell-surface engineering. Its abstract does not establish patient benefit.
-
Evidence date ·Can magnetic iron particles reshape tumors and show where immune cells go?
Review or Meta-AnalysisThe review surveys iron oxide particles designed to change tumor immune activity, carry treatments, and track immune cells. Treatment evidence remains preclinical.
-
Evidence date ·Could a drug-carrying gel keep cancer treatment near a tumour?
Review or Meta-AnalysisA review describes cell and mouse studies of porous drug carriers in injectable gels. AI's benefits and the materials' long-term safety remain unproven.
-
Evidence date ·Why the material carrying cancer immunotherapy may matter
Review or Meta-AnalysisThe review explains how hyaluronic acid could shape vaccine and chemo-immunotherapy delivery. Whether these designs help patients remains to be shown.
-
Evidence date ·One coated particle brings light and tumor chemistry together
Peer-Reviewed PaperA coated particle paired with light inhibited breast tumor growth in mice. Cell markers hint at an immune role, but do not establish one.
-
Evidence date ·How tiny albumin-based carriers are designed around solid tumors
Review or Meta-AnalysisA 2024 review explains how tumor acidity, low oxygen and immune conditions shape albumin-carrier design across cancer treatments and what remains uncertain.